Birthweight strongly linked to type 2 diabetes risk in adulthood
In a new study from the National University of Singapore, researchers found that a birth weight of 2.5 kg or more is strongly linked...
Diabetes drug may be a new weapon against HIV, study finds
In a new study from the University of North Carolina, researchers found that a widely used diabetes drug, metformin, could fight AIDS-causing retrovirus HIV.
They...
This study shows a new cause of type 2 diabetes
In a recent study at Texas Tech University, researchers found a specific group of neurons in the brain may play a crucial role in...
This health problem cause half of new diabetes cases annually in U.S.
In a new study from Northwestern University, researchers found that reducing the prevalence of obesity may prevent up to half of new Type 2...
Common drugs for type 2 diabetes and obesity do not increase breast cancer risk
In a new study from the Universidade Federal do Rio Grande do Sul, researchers found that commonly used medications for type 2 diabetes and...
Scientists find new way to reduce diabetes-related eye disease
In a new study from Indiana University, researchers found that early treatment with anti-VEGF injections reduces diabetic retinopathy.
Their 2-year results suggest that close monitoring...
Fasting acts as diet catalyst in people with metabolic syndrome
One in four Germans suffers from metabolic syndrome.
Several of four diseases of affluence occur at the same time in this 'deadly quartet': obesity, high...
Common diabetes drug could strongly cut COVID-19 death risk
In a recent study at the University of Alabama at Birmingham, researchers found that the use of the diabetes drug metformin—before a diagnosis of...
Weekly insulin can help manage type 2 diabetes effectively
In a new study, researchers found that a new once-weekly basal insulin injection demonstrated similar efficacy and safety and a lower rate of low...
Newer diabetes drug can protect kidney and heart health
In a recent study at Brigham and Women’s Hospital, researchers found new evidence that sodium/glucose cotransporter 2 (SGLT2) inhibitors can benefit patients with diabetes...